A Bispecific Antibody Based on Pertuzumab Fab Has Potent Antitumor Activity.
Deng W, Liu J, Pan H, Li L, Zhou C, Wang X, Shu R, Dong B, Cao D, Li Q, Wang Z.
Deng W, et al. Among authors: li l, li q.
J Immunother. 2018 Jan;41(1):1-8. doi: 10.1097/CJI.0000000000000200.
J Immunother. 2018.
PMID: 29232309